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T cell development requires sequential localization of
thymocyte subsets to distinct thymic microenviron-
ments. To address mechanisms governing this
segregation, we used two-photon microscopy to
visualize migration of purified thymocyte subsets
in defined microenvironments within thymic slices.
Double-negative (CD48) and double-positive
(CD4+8+) thymocytes were confined to cortex where
they moved slowly without directional bias. DP cells
accumulated and migrated more rapidly in a special-
ized inner-cortical microenvironment, but were
unable to migrate on medullary substrates. In con-
trast, CD4 single positive (SP) thymocytes migrated
directionally toward the medulla, where they
accumulated and moved very rapidly. Our results
revealed a requisite two-step process governing
CD4 SP cell medullary localization: the chemokine
receptor CCR7mediated chemotaxis of CD4 SP cells
towards medulla, whereas a distinct pertussis-toxin
sensitive pathway was required for medullary entry.
These findings suggest that developmentally regu-
lated responses to both chemotactic signals and
specific migratory substrates guide thymocytes to
specific locations in the thymus.INTRODUCTION
The thymus is composed of functionally interacting stromal and
hematolymphoid cells. Thymocytes derive from bone marrow
common lymphoid progenitors that enter the thymus from the
vasculature (Karsunky et al., 2008; Kondo et al., 1997; Serwold
et al., 2009). Maturing thymocytes migrate through spatially
distinct microenvironments where encounters with stromal cells
promote their development (Misslitz et al., 2006; Petrie and
Zu´n˜iga-Pflu¨cker, 2007). Immunostaining of fixed tissue reveals
that the most immature double negative (DN) precursors
(CD4CD8) reside at the cortico-medullary junction (CMJ),
whereas more mature DN cells are found closer to the capsule986 Immunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc.(Brahim and Osmond, 1970; Lind et al., 2001; Porritt et al.,
2003). After pre-TCR signaling, CD4 and CD8 are upregulated,
yielding double positive (DP) thymocytes (CD4+CD8+; Guidos
et al., 1989) localized throughout the cortex. DP cells that interact
with low avidity for self-peptide: MHC on cortical epithelial cells
undergo positive selection to become single positive (SP) thymo-
cytes (CD4+CD8 or CD4CD8+). SP cells localize primarily to
the medulla, where they interact with Aire+ epithelia to undergo
negative selection against tissue-restricted antigens (Hogquist
et al., 2005; Starr et al., 2003).
The migration of thymocytes through these distinct microenvi-
ronments is important for proper T cell development, as shown
by the developmental arrest that results from preventing DN
cell migration toward the capsule (Misslitz et al., 2004; Plotkin
et al., 2003; Uehara et al., 2006), or the autoimmunity that ensues
when SP cells are blocked from entering the medulla (Kurobe
et al., 2006; Ueno et al., 2004). The mechanisms contributing
to thymocyte localization are not well understood. Thymic micro-
environments may present specific substrates that regulate
adhesion or migration via interactions with developmentally
regulated receptors on thymocytes. Indeed, integrin expression
changes during thymocyte development (Misslitz et al., 2006),
and immature thymocyte subsets bind differentially to integrin
ligands (Prockop et al., 2002). If substrate restriction segregates
thymocyte subsets, then sharp boundaries for migration could
exist between microenvironments. Directly observing thymocyte
motility at such a boundary, like the CMJ, would provide
evidence to support or refute this mechanism.
Chemotaxis may also contribute to thymocyte localization.
According to this model, chemotactic signals drive DN cells to
migrate from the CMJ toward the capsule, DP cells to reverse
direction and return toward the CMJ, and SP cells to cross into
medulla (Petrie, 2003). Indeed, chemokine receptors, a subset
of G protein-coupled receptors (GPCRs), direct thymocyte
chemotaxis in vitro, and their ligands are expressed in different
regions of the thymus (Campbell et al., 1999; Misslitz et al.,
2006). However, steady-state distributions of thymocyte subsets
in fixed tissue, which help form the basis for this model, do not
allow a direct test of whether thymocyte subsets migrate direc-
tionally within the thymus.
There is a general consensus that by promoting chemotaxis,
the chemokine receptor CCR7 on SP cells provides the predom-
inant signal required for them to enter and accumulate in the
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B Figure 1. EGFP Slices Are Structurally Intact
and Support Thymocyte Migration in All
Regions
(A and B) Individual images from the cortex (A) or
medulla (B) of EGFP slices illustrate the distinct
stromal morphology in each region. Medullary
stroma are broader with sheet-like morphology,
in contrast to the reticular projections of cortical
stroma. Scale bars represent 20 mm.
(C) Flow cytometric analysis of input thymocytes
from B6-Ka mice. Shown on the left is CD4 versus
CD8 staining gated on live events. Shown on the
right is c-Kit versus CD25 staining gated on lin
CD4CD8 cells.
(D) Thymocytes migrate into both the cortex and
medulla several hours after incubation atop EGFP
slices. CMTPX-labeled thymocytes are shown in
red, and EGFP-labeled stroma are shown in green.
Dotted line approximates the CMJ. The scale
bar represents 50 mm. The image is a maximum
intensity projection (MIP) of individual Z sections.
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Developmental Control of Thymocyte Localizationmedulla (Kwan and Killeen, 2004; Kurobe et al., 2006; Ueno et al.,
2004). However, chemokine receptors may also contribute to
thymocyte motility and localization through chemokinetic effects
(Okada and Cyster, 2007; Witt and Robey, 2005) or by activating
integrins to enable migration on particular substrates (Thelen and
Stein, 2008). It is currently unclear which of these mechanisms
enable CCR7 to contribute to SP cell medullary localization
and whether additional signaling pathways are involved. Testing
these mechanisms requires real-time visualization of SP cell
migration in the cortex and medulla in the presence or absence
of specific receptors such as CCR7.
Live imaging of thymic tissue with two-photon microscopy
offers a powerful approach to test mechanisms of thymocyte
localization. Previous two-photon studies have described
patterns of thymocyte motility in the cortex and the role of
Ca2+ signals in their regulation (Bhakta et al., 2005; Witt et al.,
2005). To address mechanisms that control localization of
thymocyte subsets throughout the entire thymus, we applied
two-photon microscopy to a modified thymic slice system
(Bhakta et al., 2005) in which EGFP expression in the thymic
stroma permitted unambiguous identification of thymic com-
partments. By introducing purified thymocyte subsets into
slices, we determined the localization and motility of each devel-
opmental subset in all regions of the thymus, and we acutely
perturbed signaling pathways to assess their contributions.
Thus, we uncovered several mechanisms controlling thymocyte
localization during development. First, we found that immature
thymocytes lacked the ability to migrate on medullary stroma,
resulting in a sharp barrier that enforced strict cortical restriction.
In contrast, SP cells were able to migrate on medullary sub-
strates, and their accumulation in the medulla required chemo-
taxis. From the effects of pertussis toxin (PTX), we found thatImmunity 31, 986–998, Daccumulation of CD4 SP cells in medulla
was the result of two mechanistically
distinct GPCR-mediated processes: che-
motaxis toward the medulla, and entry
into the medulla conferred by the ability
to migrate on medullary substrates. Ourresults provide direct evidence that CCR7 underlies SP cell
chemotaxis; surprisingly, however, CCR7 was dispensable for
medullary access, implicating other GPCRs in this process.
RESULTS
The Cortex and Medulla Are Intact and Support
Thymocyte Migration in EGFP Slices
We adapted our thymic slice preparation (Bhakta et al., 2005) to
enable observation of thymocyte migration within both the
cortex and medulla. Thymi from EGFP transgenic mice (Wright
et al., 2001) were vibratome-sliced into 400 mm live tissue
sections for imaging by an upright two-photon laser scanning
microscope. Although EGFP is detectable in all cells in this
mouse, it is more highly expressed in the stroma, allowing us
to visualize stromal structures preferentially over thymocytes.
Cortical and medullary structures were clearly distinguishable
by cellular morphology; the cortex contained reticular projec-
tions typical of cortical epithelial cells, whereas the medulla
was characterized by EGFP-bright, flat sheet-like cells, charac-
teristic of medullary epithelium (Figures 1A and 1B). The identifi-
cation of thymic medulla by these morphologic criteria was
confirmed by staining with the lectin UEA-1 that binds to a subset
of medullary epithelial cells (Farr and Anderson, 1985; Figure S1
available online). Unfractionated thymocytes (Figure 1C) labeled
with the red dye CellTracker CMTPX were applied to the cut
surface of EGFP slices. After allowing the cells to crawl into the
slices over several hours, thymocytes were seen migrating in
both the cortex and medulla (Figure 1D and Movie S1). Thus,
EGFP thymic slices provide a system for directly visualizing the
migration of thymocytes in identified cortical and medullary
regions.ecember 18, 2009 ª2009 Elsevier Inc. 987
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Figure 2. Double-Negative and Double-
Positive Thymocytes Localize Exclusively
to the Cortex and Migrate Slowly and Tortu-
ously
(A and D) Flow cytometric analysis of input DN
cells from Rag2/ mice (A) or DP cells from
LN3b 3 Rag2/ mice (D).
(B and E) CMTPX-labeled double negative (DN) (B)
or double positive (DP) cells (E) (red) preferentially
localize to cortex in EGFP slices (green). Image
properties as in Figure 1D. The scale bar repre-
sents 50 mm. A duplicate image of (B) with white
circles placed over DN cells to aid in visualization
can be found in Figure S3. The apparent lower
density of DN relative to DP cells in these fields
probably reflects addition of only 1/10 the number
of thymocytes to the DN versus DP slice.
(C and F) Trajectories of individual DN (C) or DP
cells (F) at higher magnification in cortex
throughout a 17 min imaging session are dis-
played as color-coded tracks running from start
(blue) to end (white) of the timecourse, as indicated
by the time bar in (C). Major ticks represent 10 mm.
(G) Cortical DN and DP speeds. Each point repre-
sents the average speed for a single tracked cell.
Mean speeds ± SEM for each population are given
above each column and represented by a bar.
n = 261 for DN from ten imaging fields in four slices
over three experiments; n = 899 for DP from ten
imaging fields in three slices over three experi-
ments.
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Developmental Control of Thymocyte LocalizationPurified Thymocyte Subsets Localize to Their Proper
Microenvironments after Acute Seeding
of Thymic Slices
To validate the thymic slice as a model system to study thymo-
cyte localization, we investigated whether purified thymocyte
subsets added acutely to thymic slices would segregate into
the same microenvironments they populate in vivo. DN cells were
isolated fromRag2/mice (blocked pre b-selection at the CD4
CD8CD44c-KitCD25+ (DN3) stage; Figure 2A), and DP cells
were obtained from LN3b3 Rag2/ mice (blocked pre-positive
selection because TCRb is endogenously rearranged, whereas
TCRa remains in germline configuration; Serwold et al., 2007;
Figure 2D). After allowing the CMTPX-labeled cells to crawl into
the slices over several hours, we collected a series of two-photon
images throughout a 40 mm depth every 15 s, starting at least
20 mm below the cut surface. Strikingly, both DN and DP cells988 Immunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc.were found exclusively in the cortex but
not in the medulla (Figures 2B and 2E),
where they migrated tortuously and slowly
(7–8 mm/min; Figures 2C, 2F, and 2G and
Figure S2; Movies S2 and S3). Similar
results were obtained with DN cells puri-
fied from wild-type thymocytes by deple-
tion (Figure S4). These results indicate
that despite continual access to both the
cortex and medulla via the cut surface of
the slices, immature thymocytes respond
appropriately to environmental cues that
confine them to the cortex.To determine whether mature SP cells also localize properly in
slices, we enriched CD4 SP cells and CD8 SP cells by depletion
of wild-type thymocytes (Figure 3A and Figure S5A). After seed-
ing, labeled CD4 SP cells and CD8 SP cells were observed in the
cortex, but were greatly enriched in the medulla (average density
in medulla relative to cortex was 6.5 ± 0.7 for CD4 SP cells and
5.2 ± 3.0 for CD8 SP cells; Figures 3B and 6E; Figure S5B). Inter-
estingly, CD4 SP cells migrated rapidly in both cortex and
medulla (14.3 ± 0.3 and 16.3 ± 0.3 mm/min, respectively) along
relatively straight paths (Figures 3C–3E, Figure S2, and Movies
S4 and S5). CD8 SP cells also migrated rapidly (Figure S5).
Movement of both SP subsets was substantially faster and
straighter than that of immature DN or DP cells, indicating that
accelerated motility is acquired late in thymocyte development.
Together, the segregation of immature thymocytes to the cortex
and mature thymocytes to the medulla indicates that thymic
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B Figure 3. CD4 SP Cells Accumulate in the
Medulla and Migrate Rapidly in All Regions
of Thymus
(A) Flow cytometric analysis of CD4 SP cells
obtained by depletion.
(B) CMTPX-labeled CD4 SP cells (red) are localized
to both the cortex and medulla in EGFP slices
(green), but accumulate preferentially in the
medulla. A duplicate of this image with white
circles placed over CD4 SP cells to aid in visualiza-
tion can be found in Figure S3. Image properties as
in Figure 1D. The scale bar represents 50 mm.
(C and D) Time-encoded tracks of CD4 SP cells
from high-magnification cortical (C) or medullary
(D) fields imaged for 17 min. Each major tick
represents 10 mm.
(E) Average track speeds (mm/min) of cortical and
medullary CD4 SP cells. Medullary CD4 SP cells
migrate more quickly than cortical CD4 SP cells
(**p < 0.01 with the two-tailed Mann-Whitney U
test). n = 340 cells for cortex from eight imaging
fields in two slices over two experiments; n = 289
for medulla from three imaging fields in two slices
over two experiments.
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Developmental Control of Thymocyte Localizationslices provide the proper cues and microenvironments for
thymocyte localization, and thus validates their use for studies
of the underlying mechanisms.
DP Cells Accumulate near the CMJ but Are Confined
to the Cortex by Their Inability to Migrate
on Medullary Substrates
To better understand how immature thymocytes are excluded
from the medulla, we examined in detail the dynamic behavior
of DP cells near the CMJ. Upon close examination, we unexpect-
edly found that DP cells accumulated preferentially at the cortical
side of the CMJ (Figures 4A and 4B). Cells in this inner cortical
subregion moved significantly more quickly than those in
the mid or outer cortex (8.1 ± 0.2 versus 6.3 ± 0.1 and 6.4 ±
0.2 mm/min, respectively; p < 0.01 for both comparisons; Fig-
ure 4C). Cortical gradients of cell densities or velocities were
not observed for any other thymocyte subset. Thus, these resultsImmunity 31, 986–998, Dsuggest that the cortical region immedi-
ately adjacent to the CMJ is a distinct
microenvironment affecting DP cell migra-
tion and localization.
Despite this DP cell accumulation near
the CMJ, we never observed a cell enter
the medulla (of 141 cells tracked in close
proximity to the CMJ in four imaging
fields over three separate experiments;
Figure 4A). Red punctate fluorescence
was occasionally found in the medulla
but did not display the characteristic
morphology or motility of intact thymo-
cytes and was most likely cell debris
(Movie S6). A typical example of DP cell
behavior at the CMJ is shown in
Figure 4D, in which a cell advances twice
into contact with medullary stroma (time5:45 and 13:00) but retracts both times (Movie S7). The fact
that DP cells accumulate near the CMJ along a sharp boundary
argues against both a diffusible repellent from the medulla,
which is inconsistent with accumulation near the CMJ, and a
diffusible attractant in cortex, which would not be expected to
create a sharp migration barrier at the CMJ. Instead, it is likely
that the DP cells are prevented from entering the medulla either
by encountering a surface-bound medullary repellent or a
medullary substrate on which they cannot crawl, either of which
would be consistent with the observed sharp boundary at the
CMJ.
We considered the possibility that a specialized subset of cells
at the CMJ might block DP cell entry into medulla. However, we
failed to detect any DP cells migrating in medulla despite the fact
that the cells loaded on top of the slice had direct and continual
access to a complete cross-section of the medulla at the cut
surface. Given that these DP cells had the opportunity to migrateecember 18, 2009 ª2009 Elsevier Inc. 989
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Figure 4. The CMJ Presents a Functional
Barrier for Preselection DP Cells to Enter
the Medulla
(A) Time-encoded tracks of individual DP cells from
a high-magnification field at the CMJ imaged for
17 min. Note that all DP cells are found in the
cortex (left side of field) and not in the medulla
(right side) and that tracks do not cross CMJ
(representative of three slices containing 141
tracked DP cells). Occasional red fluorescence in
medulla can be distinguished from live cells by its
punctate morphology and lack of movement
(Movie S6). Each major tick represents 10 mm.
The area within the white box is displayed in (D)
at increased magnification.
(B) DP cells accumulate near the medulla. The
normalized percentage ± SEM of cells found within
50 mm increments from the medulla is displayed.
n = 876 cells analyzed from ten series (see Exper-
imental Procedures) taken from five separate
slices over two experiments.
(C) Average track speeds (mm/min) of DP cells
found in cortical subregions. Velocity increases
significantly from outer or mid to inner cortex
(**p < 0.01). CMJ, n = 141 cells from three imaging
fields in three slices over three experiments; inner
cortex, n = 244 cells from four imaging fields in
two slices over two experiments; mid cortex, n =
264 cells from four imaging fields in two slices
over two experiments; outer cortex, n = 250 cells
from four imaging fields in two slices over two
experiments; all cortex, n = 899 cells from ten
imaging fields in three slices over three experi-
ments.
(D) Example of a DP cell (<) that closely
approaches but fails to cross into the medulla.
Shown are individual Z planes taken at indicated
times. The scale bar represents 10 mm.
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Developmental Control of Thymocyte Localizationon medullary stroma without going through the CMJ, the
absence of DP cells in medulla strongly implies that cortical
restriction is imposed by the cells’ inability to migrate on medul-
lary substrates rather than by a specific barrier imposed by
specialized cells at the CMJ.
CD4 SP Cells Migrate Directionally toward the Medulla
In stark contrast to DP cells, SP cells were competent to migrate
in both cortex and medulla, but preferentially accumulated in
medulla (Figure 3). To assess the role of chemotaxis in targeting
SP cells to the medulla, we first examined whether SP cells
migrated directionally in cortex. Quantification of the net
displacement of cortical CD4 SP cells showed that that they
migrated preferentially toward the medulla (Figure 5A). These
results are consistent with previous observations of an unidenti-
fied fast-moving population of thymocytes migrating along
straight trajectories away from the capsule under positively
selecting conditions (Witt et al., 2005). A close examination of
the CMJ revealed that SP cells crossed freely between the
cortex and the medulla, but the rate of medullary entry exceeded
the rate of exit (Figures 5B and 5C and Movie S8). Given the990 Immunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc.>6-fold higher density of SP cells in the medulla relative to the
cortex, a random walk model would predict that SP cells would
leave the medulla at a greater rate than they enter. Therefore,
migration across the CMJ is directionally biased in a way that
actively promotes the enrichment of SP cells in the medulla. In
addition, 40% of all SP cell translocations across the CMJ
were directed into the cortex (Figure 5C), demonstrating that
the cells were not trapped irreversibly after entering the medulla.
Overall, these data show that the directional migration of SP cells
provides a mechanism of concentrating this subset in the
medulla and suggests that a chemical gradient, perhaps
involving chemokines, may underlie this process.
Under similar conditions, neither DN nor DP cells displayed
statistically significant bias in movement toward either the
medulla or the capsule in any cortical region (p = 0.18 for DN cells
and p = 0.35 for DP cells; Figure 5A and data not shown). This
apparently random motility is not due to a general failure of the
slice to support directional migration, as evidenced by SP cell
directionality. However, we cannot exclude the possibility that
directional bias occurs within a minor DN cell subset or on a
time scale much longer than our observation window.
AC
B Figure 5. Cortical CD4 SP Cells Demon-
strate Directional Bias toward the Medulla
and Cross the CMJ Preferentially from the
Cortex into the Medulla
(A) The graph represents the percentage of cortical
tracks for each thymocyte subset whose net
displacement after 13–17 min is toward medulla
(positive values) or toward capsule (negative
values). Dashed lines are at 50%, which would be
expected from a population with no directional
bias. CD4 SP cells display significant bias toward
medulla, while DN cells (from Rag2/) and DP
cells are not biased in either direction (*p < 0.05,
chi-square test;). n = 131 Rag2/, 465 DP, and
122 CD4 SP cell tracks each from two imaging
fields in two slices over two experiments.
(B) Time-encoded tracks of individual CD4 SP cells
from a high-magnification field clearly cross the
CMJ (dashed line) in both directions over the
17min imaging period.Major ticks represent10mm.
(C) The graph represents the percentage of CD4
SP cell crossing events at the CMJ over 17 min
time courses that are toward the medulla (positive
values) or toward the cortex (negative values).
Dashed lines are at 50%, which would be expected
if there were no retention or preferential attraction
in either region. WT CD4 SP cells cross preferen-
tially from the cortex to the medulla, indicating
attraction toward and/or retention within the
medulla (*p < 0.05, chi-square test;). n = 151 WT
CD4 SP cell crossing events from six imaging fields
over two experiments.
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Developmental Control of Thymocyte LocalizationPertussis Toxin Reveals Two Distinct GPCR-Mediated
Processes that Control the Accumulation
of CD4 SP Cells in the Medulla
Multiple chemokines are known to stimulate motility (chemoki-
nesis) and directional migration (chemotaxis) of thymocytes
(Campbell et al., 1999). Therefore, we initially tested whether
treatment with PTX, which inhibits the GTP-binding proteins Gi
and Go and thereby blocks signaling from chemokine receptors
and other GPCRs, would affect the movement and localization of
CD4 SP cells. We treated CD4 SP cells with 100 ng/ml PTX for
10 min and layered them on EGFP slices for several hours prior
to imaging. This short treatment exploits a temporal window
in which PTX binds but does not yet inactivate Gi or Go (As-
perti-Boursin et al., 2007; Okada and Cyster, 2007), providing
thymocytes an opportunity to enter EGFP slices before GPCRs
are inactivated.
PTX had three distinct effects on CD4 SP cell localization and
movement. First, it eliminated directional bias of cortical CD4 SP
cells toward the medulla. Indeed, motility of PTX-treated CD4 SP
cells was not biased toward either medulla or capsule, whereas
CD4 SP cells treated with the control pertussis toxin B oligomer
(suB), which binds like PTX to receptors but does not inactivate
Gi or Go, were still biased toward the medulla (Figure 6A). These
results demonstrate that GPCR signaling is necessary for direc-
tional migration of CD4 SP cells toward the medulla, consistent
with a role for chemokines in this process.
A second effect of PTX was to reduce cortical CD4 SP cell
velocities relative to suB-treated or untreated controls (8.5 ±
0.2 versus 10.0 ± 0.2 and 14.3 ± 0.3 mm/min, respectively;IFigure 6B). It should be noted that some of the slowing effect
of PTX may be independent of Gi or Go inhibition because
suB partially slowed migration. Interestingly, suB is known to
block chemokine receptors and induce [Ca2+]i elevation in
lymphocytes, both of which are possible mechanisms for the
slowing of cells by suB (Alfano et al., 1999; Strnad and Carch-
man, 1987; Wong and Rosoff, 1996). Nevertheless, the sig-
nificant difference (p < 0.01) in velocities between suB and
PTX treatments indicates a role for GPCRs in CD4 SP cell
chemokinesis.
Importantly, the third effect of PTX was a pronounced exclu-
sion of CD4 SP cells from the medulla. Whereas untreated and
suB-treated CD4 SP cells accumulated in the medulla (reaching
medullary:cortical density ratios of 6.5 ± 0.7 and 4.9 ± 2.1,
respectively), PTX-treated CD4 SP cells did not (medullary:cort-
ical density ratio of 0.4 ± 0.2; Figures 6C–6E and Movies S9 and
S10). Indeed, many medullary fields contained no detectable
PTX-treated CD4 SP cells. If chemotaxis were the sole mecha-
nism driving the accumulation of CD4 SP cells in the medulla,
blocking chemotaxis with PTX would be expected to produce
an equal distribution of cells between the cortex and the medulla.
However, we did not observe this result. The extreme paucity
of CD4 SP cells in the medulla after PTX treatment therefore
suggests that a GPCR-mediated mechanism distinct from
chemotaxis contributes to the preferential accumulation of
untreated CD4 SP cells in the medulla. The most likely explana-
tion of these results is that in addition to driving chemotaxis,
GPCR activity is also required for entry into the medulla by
enabling SP cells to migrate on medullary substrates.mmunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc. 991
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Medullary Entry Step
(A) PTX treatment eliminates CD4 SP cell medullary
bias (**p < 0.01; *p < 0.05). Analysis as in Figure 5A.
Time courses ranged from 8–17 min for PTX and
11–16 min for suB. PTX, n = 572 tracks from three
imaging fields in two slices over two experiments;
suB, n = 508 tracks from three imaging fields in
three slices over two experiments. For compar-
ison, untreated data are duplicated from Figure 5A.
(B) PTX treatment reduces the speed of cortical
CD4 SP cells relative to untreated and suB-treated
CD4 SP cells (**p < 0.01, nonparametric one-way
ANOVA, followed by Dunn’s post test). PTX, n =
691 cells from five imaging fields in four slices
over two experiments; suB, n = 508 cells from three
imaging fields in three slices over two experiments.
For comparison, untreated data are duplicated
from Figure 3.
(C and D) CMTPX-labeled CD4 SP cells (red) are
rarely found in the medulla after PTX treatment
(C) but readily enter the medulla after suB control
treatment (D). Time-encoded tracks of cell trajec-
tories from a low-magnification field of slices
containing CD4 SP cells pretreated with 100 ng/ml
PTX (C) or suB (D) and imaged for 8 min (C) or
11 min (D). Major ticks represent 20 mm.
(E) PTX treatment inhibits CD4 SP cells from
entering medulla. The density of CD4 SP cells in
the medulla relative to the cortex was determined
in multiple low-magnification fields and then ratios
were averaged for different fields, indicating the
average fold enrichment of cells in the medulla
relative to the cortex (±SEM). Although untreated
CD4 SP cells are enriched 6.5-fold in the medulla
relative to the cortex, PTX treatment results in a
medullary:cortical density ratio of 0.4, indicating
that GPCR blockade actively prevents cells from
entering the medulla. Untreated, n = 1593 cells
from nine imaging fields in six slices from four
experiments; suB, n = 821 cells from five imaging
fields in four slices in three experiments; PTX, n =
685 cells from ten imaging fields in five slices
from three experiments.
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Developmental Control of Thymocyte LocalizationCCR7 Is Required for CD4 SP Cell Chemotaxis
but Not for Migration in the Medulla
Upregulation of CCR7 after positive selection, as well as the
effects of CCR7 ectopic expression or deficiency on thymocyte
localization, has prompted the widely held view that CCR7 is
necessary and sufficient to drive SP cell chemotaxis, entry,
and accumulation in the medulla (Kurobe et al., 2006; Kwan
and Killeen, 2004; Ueno et al., 2004). Therefore, we investigated
whether loss of CCR7 function could explain all three effects of
PTX. Ccr7/ CD4 SP cells introduced into wild-type (WT)
EGFP slices no longer displayed directional bias toward the
medulla, but instead were slightly oriented toward the capsule
(Figure 7A). This result is a direct demonstration that CCR7 is
necessary for chemotaxis toward the medulla and implies that
CCR7 inhibition is the mechanism by which PTX blocks SP cell
migration toward medulla.
Although migration of Ccr7/ CD4 SP cells in the cortex was
relatively rapid (11.6 ± 0.2 mm/min; Figure 7B and Movie S11), it
was significantly slowed relative to wild-type CD4 SP cells992 Immunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc.(compare Figure 7B to Figure 6B, p < 0.01). Thus, CCR7 also
contributes to SP cell chemokinesis (Figure 6B), similar to its
chemokinetic effect on mature lymphocytes in lymph nodes
(Asperti-Boursin et al., 2007; Okada and Cyster, 2007; Worbs
et al., 2007).
Given the currently held view that CCR7 is required for med-
ullary entry, we were particularly surprised to find abundant
Ccr7/ CD4 SP cells in the medulla. These cells were migrating
vigorously (12.8 ± 0.4 mm/min; Figures 7B–7D and Movie S12),
indicating that CCR7 is dispensable for allowing productive
movement on medullary substrates. Because medullary entry
of Ccr7/ CD4 SP cells was unexpected, we questioned
whether they were capable of crossing the CMJ into medulla
or whether they only entered this region via the cut surface of
the slice. In multiple high magnification CMJ fields, we directly
observed Ccr7/ CD4 SP cells crossing from the cortex into
the medulla (Figure S6A). However, in contrast to WT CD4 SP
cells, which preferentially cross the CMJ from the cortex to the
medulla, Ccr7/ CD4 SP cells cross the CMJ bidirectionally at
AC D
E F
B Figure 7. CCR7 Is Responsible for CD4 SP
Cell Chemotaxis toward the Medulla, but Is
Not Necessary for Medullary Entry
(A) Ccr7/ CD4 SP cells no longer display direc-
tional bias toward medulla, but instead migrate
toward capsule. Data were analyzed over 17 min
period. Analysis as in Figure 5A (**p < 0.01; *p <
0.05). Ccr7/, n = 602 cells from two fields in
two slices over two experiments. For comparison,
WT CD4 SP cell data is duplicated from Figure 5A.
(B)Ccr7/CD4 SP cells migrate rapidly in both the
cortex and medulla, although medullary migration
is faster (*p < 0.05). Cortex, n = 602 cells from
two imaging fields over two experiments; medulla,
n = 110 cells from two imaging fields in two slices
over two experiments.
(C) CMTPX-labeled Ccr7/ CD4 SP cells (red) are
found in the cortex, but are also present in the
medulla in EGFP slices (green). Data collected
over 17 min. Major ticks represent 20 mm.
(D) Ccr7/ CD4 SP cells migrate productively in
medulla, as shown by time-encoded tracks from
high-magnification medullary fields imaged for
15 min. Major ticks represent 10 mm.
(E) Ccr7/ CD4 SP cells do not accumulate in
medulla to the same extent as WT CD4 SP cells.
CMTPX-labeled Ccr7/ CD4 SP cells (red) and
indo-PE3-labeled WT CD4 SP cells (blue) were
added to the same EGFP thymic slice. Whereas
WT cells clearly accumulate in medulla, Ccr7/
CD4 SP cells are more evenly distributed across
the cortex and medulla. Major ticks represent 20mm.
(F) Ccr7/ CD4 SP cells fail to accumulate in the
medulla, but are not blocked from medullary entry.
Analysis as in Figure 6E; for comparison, all WT
data are duplicated from Figure 6E. In contrast to
the 6.5-fold accumulation of WT CD4 SP cells in
the medulla, Ccr7/ CD4 SP cells accumulate
only 1.6-fold in the medulla relative to the cortex.
Furthermore, Ccr7/ CD4 SP cells are sensitive
to PTX, which reduces the medullary:cortical
density ratio to 0.6. For Ccr7/ CD4 SP cells:
untreated, n = 1361 cells from 11 imaging fields
in eight slices over four experiments; suB, n =
476 cells from four imaging fields in two slices
over two experiments; PTX, n = 185 cells from
four imaging fields in two slices over two experiments. These analyses include data from slices in which two populations were differentially labeled (CMTPX
versus Indo-PE3) and added simultaneously to the slice as follows: three imaging fields with PTX-treated and suB-treated Ccr7/ CD4 SP cells; two imaging
fields with PTX-treated and suB-treated WT CD4 SP cells; and six imaging fields with untreated WT and untreated Ccr7/ CD4 SP cells, as in (D). The relative
medullary:cortical enrichments we observed were not significantly different between the slices containing one of the above populations or two differentially
labeled populations, so the two data sets were combined.
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the absence of CCR7 (Figure S6B). Evidently, SP cells do not
require CCR7 to enter the medulla or to migrate freely on medul-
lary substrates.
When labeled with different dyes and added simultaneously to
the same slice, it was clear that Ccr7/ CD4 SP cells accumu-
lated to a much lesser extent than WT CD4 SP cells in the
medulla (Figure 7E). The medullary:cortical density ratio for
Ccr7/ CD4 SP cells was 1.6 ± 0.1 compared to 6.5 ± 0.7 for
WT CD4 SP cells (Figure 7F). Thus, CCR7 is required for CD4
SP cells to accumulate in the medulla, consistent with its chemo-
tactic effect, but it is not required for the cells to enter the medulla
and migrate on medullary substrates. Importantly, the nearly
even distribution of Ccr7/ CD4 SP cells between the medullaIand the cortex would be expected if CCR7 deficiency simply
prevents CD4 SP cell chemotaxis. The much lower accumulation
of medullary cells after PTX treatment (medullary:cortical ratio of
0.4 ± 0.2) therefore implies that a GPCR other than CCR7 plays
the critical role in enabling medullary entry. PTX-treated Ccr7/
CD4 SP cells were inhibited from entering medulla to a similar
extent as PTX-treated WT cells (medullary:cortical density ratio
0.6 ± 0.2 for Ccr7/ after PTX; Figure 7F), demonstrating
that the Ccr7/ CD4 SP cells had not undergone compensatory
upregulation of a PTX-insensitive protein to gain access to the
medulla.
In sum, CCR7 deficiency prevents CD4 SP cell chemotaxis
and chemokinesis, replicating two effects of PTX, but surpris-
ingly and unlike PTX, does not block the ability of CD4 SP cellsmmunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc. 993
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two mechanisms, CCR7-mediated chemotaxis and medullary
migration under the control of a distinct GPCR, act in concert
to properly target CD4 SP cells to the medulla.
DISCUSSION
In this study, we introduce the thymic slice as a system for exam-
ining mechanisms of thymocyte migration and localization
during development. The slice offers a number of advantages
for these studies: the slice presents the mature 3D structure of
cortical and medullary compartments and provides the appro-
priate cues to restrict DN, DP, and SP cell subsets to their proper
microenvironments. The motility and directionality of DP and SP
cells in slices (Bhakta et al., 2005; this study) are similar to those
observed in intact thymic lobes (Le Borgne et al., 2009; Ladi
et al., 2008; Witt et al., 2005), and the slice can deliver endoge-
nous chemotactic signals, as demonstrated by CCR7-depen-
dent CD4 SP cell chemotaxis toward the medulla. Although the
preservation of endogenous chemotactic signals supported
the directional migration of SP cells in this study, we cannot
rule out chemotactic mechanisms influencing the localization
of DN and DP cells solely on the basis of their apparent absence
of directional bias in the slice. It is possible that weak chemokine
gradients may be perturbed when the thymus is sliced, or that
directional bias for DN cells (or a minor DN subset) and DP cells
that redistribute slowly over days may simply be undetectable
during the relatively brief observation windows possible with
the slice (<several hours). Despite these potential limitations,
the ability to seed slices with purified populations of labeled
thymocyte subsets, to delineate stromal compartments with
EGFP, and to acutely perturb thymocyte signaling pathways
offers a powerful new approach to directly query the mecha-
nisms that localize thymocytes at known developmental stages
to distinct microenvironments.
We used the thymic slice to investigate mechanisms that
determine the cortical localization of DN and DP cells. By
closely observing DP cell motility near the CMJ, we showed
that the boundary blocking DP cell medullary entry is abrupt
but does not appear to arise from a specialized subset of cells
preventing access at the CMJ because DN and DP cells applied
directly to medullary stromal cells at the slice surface also failed
to enter the medulla. Instead, immature thymocytes appear
unable to migrate on medullary stroma, suggesting that
substrate restriction is the basis for their confinement to the
cortex. Substrate restriction has been well documented in
peripheral lymphoid organs, where it is thought to restrict T
and B cells to their respective zones in lymph nodes and the
spleen (Baje´noff et al., 2006; Baje´noff et al., 2008). How
substrate restriction is achieved in the thymus is unknown, but
it could result from either active repulsion from the medulla
or a lack of thymocyte receptors for medullary substrates.
Because DP cells accumulate directly adjacent to the CMJ, if
a repulsive cue exists it must be highly localized, perhaps bound
to the surface of medullary stromal cells or ECM. Interestingly,
semaphorins, which generate repulsive signals to control
boundary formation in the nervous system, are also expressed
in thymic medulla, raising the possibility of an analogous role
in thymocyte segregation (Choi et al., 2008; Mendes-da-Cruz994 Immunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc.et al., 2009). In addition, because cortical and medullary epithe-
lial cells are distinct (Derbinski et al., 2005), they may express
different adhesion molecules, such as integrin ligands (Misslitz
et al., 2006), which could restrict thymocyte subsets to these
different regions.
Unexpectedly, a close examination of DP cell behavior in
different cortical regions revealed a unique functional microenvi-
ronment in the thymic cortex adjacent to the CMJ. DP cells
accumulate in this area and migrate more rapidly than else-
where in the cortex. The existence of a specialized compart-
ment near the CMJ is consistent with a recent study in which
pre- and postpositive selection DP cells were reported to accu-
mulate in the inner cortex of a positively selecting thymus. In a
negatively selecting background, dying caspase 3+ DP cells
were also enriched in this region (McCaughtry et al., 2008).
These findings suggest that delivery of positive and negative
selection signals may be enhanced in the inner cortex and
that the accumulation of DP cells in this region may poise
them to be selected near the medulla, where they will subse-
quently undergo the final stages of development. It is tempting
to think that their accumulation and higher speeds are a
response to a weak chemoattractant released from the medulla,
which they cannot enter. Further work will be needed to test this
and other possible models.
In contrast to the slow tortuous migration of DN and DP cells,
SP cells moved much more rapidly and followed straighter
trajectories. SP cells migrate at the highest known speeds of
any lymphoid cell, exceeding even those of mature T cells (16
versus 8–12 mm/min, respectively; Bousso and Robey, 2003;
Mempel et al., 2004; Miller et al., 2003; Miller et al., 2002; Tang
et al., 2006); similar speeds were reported in a study of medullary
thymocytes in thymic lobes while this paper was under review
(Le Borgne et al., 2009). The high speed of mature T cells is
thought to enable efficient scanning of antigen-presenting
dendritic cells in lymph nodes (Bousso and Robey, 2003; Miller
et al., 2004). In the thymic medulla, deletion of autoreactive SP
cells depends on the effective detection of rare tissue-restricted
self-antigens (Anderson et al., 2002; Derbinski et al., 2008; Der-
binski et al., 2001; Gallegos and Bevan, 2004; Tykocinski et al.,
2008). The short residence time of SP cells in medulla (4 days;
McCaughtry et al., 2007) coupled with the small number of
thymic epithelial cells that display any given tissue-restricted
antigen (1000) creates a challenge for inducing complete
central tolerance (Kyewski and Klein, 2006). Thus, the rapid
motility of SP cells may provide a means to optimize scanning
of the full repertoire of sparsely displayed tissue-restricted
antigens within the medulla.
In this study, we primarily focused on the central question of
how the characteristic localizations of DN, DP, and SP thymo-
cytes are established; in particular, what restricts DN and DP
cells to the cortex, and what promotes the accumulation of SP
cells in the medulla? Previous work suggested a prominent
role for CCR7 in these processes. The absence of CCR7 on
immature thymocytes was thought to be central to exclusion of
these cells from medulla, whereas acquisition of CCR7 after
positive selection was believed to drive a chemotactic response
that attracts SP cells toward the medulla and allows them to
enter and accumulate in this region (Kurobe et al., 2006; Kwan
and Killeen, 2004; Ueno et al., 2004). Given that we could acutely
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and subsequently observe their localization and motility, we
were able to directly assess the roles of chemokine receptors
in general and CCR7 specifically in controlling medullary
localization.
A general blockade of signaling through all chemokine recep-
tors and other GPCRs by PTX had three effects on CD4 SP cell
localization and migration: it abrogated directional migration
toward the medulla, it slowed cortical motility, and it largely
prevented medullary access. Given the expected contribution
of CCR7 to all of these processes, we directly examined
whether CCR7 deficiency would recapitulate all three PTX
effects. Ccr7/ CD4 SP cells move more slowly than WT
CD4 SP cells and fail to chemotax toward the medulla,
providing direct confirmation that CCR7 contributes to chemo-
kinesis of SP cells and is necessary for attracting them toward
the medulla. If other chemokine receptors also contribute to
CD4 SP cell chemotaxis toward the medulla, then they are
apparently insufficient to support chemotaxis in the absence
of CCR7. Importantly, however, CCR7 was not required for
medullary entry of CD4 SP/ cells. Ccr7/ cells localized
roughly evenly between the cortex and the medulla and crossed
the CMJ bidirectionally at an equal frequency, indicating that
they can enter and crawl in medulla but that their inability to
chemotax prevents their medullary accumulation. The much
reduced density of PTX-treated WT SP cells in medulla relative
to Ccr7/ cells indicates that a GPCR distinct from CCR7
controls access to the medulla. This conclusion is at odds
with previous work suggesting that CCR7 is necessary and
sufficient for medullary localization. However, in one set of
studies (Kurobe et al., 2006; Ueno et al., 2004), Ccr7/ cells
were actually present at a low frequency in the medulla, indi-
cating that entry was not inhibited; rather, the cells merely
showed a defect in accumulation, consistent with our results
with Ccr7/ cells and attributable to the lack of chemotaxis.
Similarly, in the study claiming that ectopic expression caused
immature thymocytes to home to the medulla, DP cells express-
ing CCR7 primarily accumulated at the perimeter of the medulla,
as expected from enhanced chemotaxis, but on close examina-
tion did not efficiently enter the medulla (Kwan and Killeen,
2004).
In sum, our data suggest that during development, two key
events lead from the cortical localization of DP cells to the
medullary accumulation of SP cells. After positive selection,
chemotaxis toward the medulla is enabled through the acquisi-
tion of CCR7, and medullary entry and migration is enabled by
acquisition of the ability to migrate on medullary substrates.
This may come about as a result of acquiring a GPCR signaling
system that is required for medullary migration or from the loss of
sensitivity to a repulsive medullary signal. Regarding the former
possibility, it is interesting that chemokine receptors are known
to activate integrins that regulate substrate adhesion during
the extravasation of mature T cells from the circulation into
inflamed tissue (Campbell et al., 2003; Thelen and Stein, 2008).
An analogous mechanism may control the ability to migrate on
medullary substrates efficiently in a PTX-sensitive manner. By
exposing the multiple steps in medullary accumulation, these
results point the way toward a molecular description of this
essential event in T cell development.IEXPERIMENTAL PROCEDURES
Mice
C57BL/Ka, Rag2/Ly5.2, LN3b 3 Rag2/ (Serwold et al., 2007), and mice
transgenic for EGFP under control of the b-actin promoter (Wright et al.,
2001) were maintained in our laboratory. CCR7-deficient mice on a C57BL/
6J background were obtained from the Jackson Laboratory or from Jason
Cyster (University of California San Francisco). All mice used were MHC
matched. Mice were used between 3 and 8 weeks of age. All mice were
maintained in accordance with Institutional Animal Care and Use Committee
guidelines.
Antibodies
Protein-G purified antibodies against CD4 (GK1.5), CD8 (53-6.7), CD25
(PC.61), Mac-1 (M1/70), Gr-1 (8C5), B220 (6b2), Ter119 (ter119), and CD11c
were purified from hybridomas and used for cell depletions. For flow cytome-
try, the following directly fluorophore conjugated antibodies were used
and were conjugated in-house unless otherwise indicated: goat anti-rat
tricolor (Invitrogen), CD4-Alexa Fluor 647, CD8-Alexa Fluor 488, CD3-biotin
(KT31.1), gamma-delta-PE (GL3; BD Biosciences PharMingen), CD11c-
Cy5.5PE (N418; eBioscience), NK1.1-Cy7PE (PK136; eBioscience), CD19-
Alexa Fluor 700 (eBio1D3; eBioscience), c-Kit-Alexa Fluor 750 (2B8;
eBioscience), Mac-1-Pacific Blue, and CD25-Pacific Orange. Streptavidin
conjugated to Q605 or Q655 (Invitrogen) was used for biotin detection. For
conjugations, the following were used: biotin (Pierce Chemical), Pacific Blue,
Pacific Orange, and Alexa Fluor 488 or 647 (Invitrogen). For slice staining,
biotin-conjugated UEA-1 (Sigma-Aldrich) was incubated with the slice and
then detected with Texas Red-conjugated streptavidin (BD PharMingen).
Flow cytometry was performed on a FACSAria (BD Biosciences), and analysis
was carried out with FlowJo (TreeStar).
Media
Full RPMI media contained the following: RPMI 1640 medium (Cellgro) supple-
mented with 2 mM L-glutamine, 50 U/ml of penicillin, 50 mg/ml of streptomycin,
and 10% fetal bovine serum (FBS). DRPMI media contained the following:
powdered RPMI 1640 medium deficient in phenol red (Cellgro) plus 0.2 g/L
of NaHCO3 and 20 mM HEPES. Slice perfusion media contained the following:
powdered RPMI 1640 medium deficient in phenol red supplemented with 2 g/L
of NaHCO3, 5 mM HEPES, and 0.85 mM CaCl2 (total [Ca
2+] = 1.25 mM).
Slice Preparation and Imaging
Vibratome-cut thymic slices were prepared as described (Bhakta et al., 2005),
with some modifications. Slices were cut from EGFP thymi. For labeling,
thymocytes were isolated in DRPMI medium + 10% FBS; 1 to 103 106 thymo-
cytes were labeled with 5 mM CellTracker CMTPX (Invitrogen) in 1.5 ml DRPMI
medium without serum for 30 min at 37C/6% CO2 and then destained in
1.5 ml full RPMI for 30 min at 37C/6% CO2. Labeled thymocytes were washed
twice with full RPMI and layered on slices inside a ring of silicone grease; cells
migrated into slices for at least 3 hr at 37C/6% CO2 before imaging. In indi-
cated experiments, thymocytes were labeled with Indo-PE3 (Teflabs) for
1.5 hr in full RPMI, washed once, and added to EGFP slices along with
CMTPX-labeled cells. In some experiments, CMTPX-labeled or Indo-PE3-
labeled thymocytes were treated with 100 ng/ml pertussis toxin (PTX) or its
B oligomer (suB) for 10 min at 37C/6% CO2 in 1 ml full RPMI, washed twice
with full RPMI and then layered on slices.
Two-photon imaging was conducted on a custom-built upright microscope
(Sutter Instruments), with a mode-locked Ti:sapphire laser tuned to 850 nm
(Mira 900, Coherent) and either a 203/0.95 NA (XLUMPlanFl, Olympus) or
a 633/0.9 NA (Achroplan, Zeiss) objective. Emitted light was passed through
535/50 and 610/50 bandpass filters (Chroma) to separate photomultipliers for
detection of EGFP and CMTPX fluorescence, respectively. Acquisition was
controlled with MPScope software (Nguyen et al., 2006); typically, Z stacks
of 483 3 483 3 40 mm (203 objective) or 152 3 152 3 40 mm (633 objective)
were acquired every 15 s, with Z steps spaced 5 mm apart. Imaging was done
roughly 20–60 mm beneath the cut surface of the slice for ensuring intact tissue
structure. A Pockels cell (Conoptics) was used for stepping laser power while
moving deeper into tissue during acquisition. In cases where both CMTPX-
and Indo-PE3-labeled cells were imaged in the same slice, images were firstmmunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc. 995
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as described above The laser was then retuned to 710 nm and additional Z
stacks through 40 mm of the same region were acquired at 15 s intervals
with a 480/120 m-2p filter to collect emitted Indo-PE3 fluorescence.
During imaging, slices were immobilized with a slice anchor within a chamber
(RC-26GLP, Warner Instruments). Slices were continuously perfused with
oxygenated slice buffer (95% O2/5% CO2) at a rate of 1 ml/min; a heated
chamber platform (Warner) and inline perfusion heater maintained the
chamber temperature at 36C. Slices were imaged from 3 to 9 hr after thymo-
cyte seeding with no appreciable change in results.
Purification of Thymocyte Subsets
When indicated, prior to CMTPX labeling, C57BL/Ka thymocytes were
depleted by immunomagnetic separation with mAbs against non-T lineages:
B220, Mac-1, Gr-1, Ter119, and CD11c. mAbs against CD4 and CD8 were
used for DN cell enrichments; CD8 + CD25 or CD4 + CD25 were used for
obtaining CD4 SP cells or CD8 SP cells, respectively. Thymocytes were
incubated with the depleting antibodies for 30 min on ice in PBS + 10%
FBS, and were then incubated with anti-rat magnetic beads (Dynal) at a ratio
of 2 cells:1 bead; this was followed by magnetic depletion of bound cells.
A second round of depletion was carried out with half the number of beads
to improve enrichments. Flow cytometry was conducted after purification,
and typical purities were >95% (DN), >90% (CD4SP), and 78% (CD8 SP),
with <1% of cells which had escaped depletion.
Image Analysis
Imaris 6.0 (Bitplane AG) was used for tracking cell positions over time. Track
speeds equals path length divided by time observed. In some analyses of
low-magnification fields, cortex was divided into equal thirds, and speeds
were determined within these subregions. Track straightness equals dis-
placement (end subtracted by start position) divided by path length, with
a value of 1.0 representing a perfectly straight trajectory. Red fluorescence
outside of thymic capsule represents cells not in tissue and was ignored
(Figures 6 and 7).
To quantify directional bias, we analyzed tracks from low-magnification
fields for their net displacement in the axis orthogonal to the CMJ and the
capsule. Fields used for this analysis exhibited optimal slice orientation where
the CMJ and capsule were both visible and roughly parallel to each other. For
some fields, we rotated the coordinates with trigonometric functions to facili-
tate analysis. The percentages of tracks whose net displacement was toward
or away from the medulla were quantified. By convention, positive values
indicate net movement toward the medulla.
Relative enrichment of cells in the medulla versus the cortex was determined
from low-magnification fields: the number of cells in medulla or cortex at
a single time point was normalized to the total volume of those regions for
obtaining cortical or medullary cellular densities. The ratio of medullary density
to cortical density was determined for each imaging field, and these ratios
were averaged to yield the average fold enrichment in medulla relative to the
cortex.
To quantify DP density as a function of distance from medulla, we collected
a series of adjacent Z stacks (either 21 3 2 mm or 15 3 5 mm) at high magnifi-
cation (633), starting in the medulla and moving laterally toward the capsule
along either the x or y axis with each successive Z stack. The lateral distance
of each cell from the CMJ was binned in 50 mm increments, for ten series.
Distance varied from the medulla to capsule in each series, so only the first
400 mm of the cortex away from the medulla, where the majority of series
contributed to the analysis, were considered. The percentage of cells within
each bin was calculated for each series individually for normalization of the
total number of cells within that series. The percentage of cells in each bin
were then averaged across the ten series, and plotted.
To calculate the number of events that crossed the CMJ in either direction,
we analyzed multiple high-magnification CMJ imaging fields containing either
WT or Ccr7/ CD4 SP cells. Each time a cell crossed the CMJ, one crossing
event was counted either in the direction of the cortex or the medulla. The
percentage of events crossing in either direction was then determined and
graphed for both populations. For all analyses, we report in the figure legends
the number of cells analyzed in a given number of imaging fields, recorded in
a given number of slices over a number of separate experiments, which were996 Immunity 31, 986–998, December 18, 2009 ª2009 Elsevier Inc.performed on different days. The slices imaged on a given day were some-
times mixed from two mice, so the number of experiments provides a minimum
number of mice used in a given analysis.
Statistics
Prism 5.0 (GraphPad) and Microsoft Excel were used for all statistical
analyses. Because the populations tested were not normally distributed, as
determined by the KS test, nonparametric analyses were performed, with
the exception of the chi-square test. For comparison of average track speeds,
the two-tailed Mann-Whitney U test was used. For cases in which more than
two-way comparisons are considered, we ran a nonparametric one-way
ANOVA (Kruskal-Wallis) test, followed by Dunn’s multiple comparison post
test. For analyses of directional bias and CMJ crossing, we used a chi-square
test to assess whether the number of tracks or events displacing or crossing
toward and away from the medulla was significantly different from a random
distribution.
SUPPLEMENTAL DATA
Supplemental Data include six figures and twelve movies and can be found
with this article online at http://www.cell.com/immunity/supplemental/S1074-
7613(09)00497-X.
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